Investors with losses over $100,000 urged to act in Capricor Therapeutics class action
A securities class action lawsuit has been filed against Capricor Therapeutics, Inc. Investors who sustained losses exceeding $100,000 have until September 28, 2026, to seek lead plaintiff status.
Investors who suffered losses of more than $100,000 due to a decline in the stock of Capricor Therapeutics, Inc. are being notified of a class action lawsuit. The deadline for these investors to file applications to be appointed lead plaintiff is September 28, 2026.
The lawsuit alleges that Capricor Therapeutics made misleading statements and failed to disclose material information to investors. These alleged omissions or misrepresentations are said to have negatively impacted the company's financial standing and future prospects, leading to financial harm for shareholders.
This legal action pertains to purchasers of Capricor Therapeutics securities during a specified period, which will be detailed in the court filings. Affected investors are advised to understand their rights and the implications of the lawsuit before the upcoming deadline.
Further details regarding the legal proceedings and how to potentially participate are available through the legal counsel representing the plaintiffs. Capricor Therapeutics has not yet issued a public statement regarding this matter.